Software - Application
Compare Stocks
5 / 10Stock Comparison
EGHT vs LPSN vs NICE vs FIVN vs ZM
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Application
Software - Application
Software - Infrastructure
Software - Application
EGHT vs LPSN vs NICE vs FIVN vs ZM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Application | Software - Application | Software - Application | Software - Infrastructure | Software - Application |
| Market Cap | $372M | $32M | $5.78B | $1.70B | $33.30B |
| Revenue (TTM) | $728M | $244M | $2.95B | $1.17B | $4.87B |
| Net Income (TTM) | $-4M | $-67M | $612M | $57M | $1.90B |
| Gross Margin | 65.7% | 62.2% | 66.4% | 55.1% | 77.0% |
| Operating Margin | 2.6% | -9.6% | 21.9% | 4.7% | 23.1% |
| Forward P/E | 7.3x | — | 8.7x | 7.0x | 18.4x |
| Total Debt | $410M | $392M | $164M | $847M | $31M |
| Cash & Equiv. | $88M | $95M | $379M | $232M | $1.27B |
EGHT vs LPSN vs NICE vs FIVN vs ZM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| 8x8, Inc. (EGHT) | 100 | 18.4 | -81.6% |
| LivePerson, Inc. (LPSN) | 100 | 0.5 | -99.5% |
| NICE Ltd. (NICE) | 100 | 51.4 | -48.6% |
| Five9, Inc. (FIVN) | 100 | 21.3 | -78.7% |
| Zoom Communications… (ZM) | 100 | 60.4 | -39.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: EGHT vs LPSN vs NICE vs FIVN vs ZM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
EGHT ranks third and is worth considering specifically for momentum.
- +51.7% vs LPSN's -77.1%
Among these 5 stocks, LPSN doesn't own a clear edge in any measured category.
NICE has the current edge in this matchup, primarily because of its strength in income & stability and valuation efficiency.
- Dividend streak 0 yrs, beta 0.72
- PEG 0.33 vs ZM's 0.82
- Lower P/E (8.7x vs 18.4x), PEG 0.33 vs 0.82
- Beta 0.72 vs LPSN's 2.05
FIVN is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth 10.3%, EPS growth 370.6%, 3Y rev CAGR 13.8%
- 125.4% 10Y total return vs ZM's 74.8%
- 10.3% revenue growth vs LPSN's -22.0%
ZM is the #2 pick in this set and the best alternative if sleep-well-at-night and defensive is your priority.
- Lower volatility, beta 0.95, Low D/E 0.3%, current ratio 4.33x
- Beta 0.95, current ratio 4.33x
- 39.0% margin vs LPSN's -27.6%
- 15.9% ROA vs LPSN's -12.4%, ROIC 10.4% vs -6.6%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 10.3% revenue growth vs LPSN's -22.0% | |
| Value | Lower P/E (8.7x vs 18.4x), PEG 0.33 vs 0.82 | |
| Quality / Margins | 39.0% margin vs LPSN's -27.6% | |
| Stability / Safety | Beta 0.72 vs LPSN's 2.05 | |
| Dividends | Tie | None of these 5 stocks pay a meaningful dividend |
| Momentum (1Y) | +51.7% vs LPSN's -77.1% | |
| Efficiency (ROA) | 15.9% ROA vs LPSN's -12.4%, ROIC 10.4% vs -6.6% |
EGHT vs LPSN vs NICE vs FIVN vs ZM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
EGHT vs LPSN vs NICE vs FIVN vs ZM — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ZM leads in 2 of 6 categories
NICE leads 1 • EGHT leads 0 • LPSN leads 0 • FIVN leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
ZM leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ZM is the larger business by revenue, generating $4.9B annually — 20.0x LPSN's $244M. ZM is the more profitable business, keeping 39.0% of every revenue dollar as net income compared to LPSN's -27.6%. On growth, FIVN holds the edge at +9.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $728M | $244M | $2.9B | $1.2B | $4.9B |
| EBITDAEarnings before interest/tax | $48M | -$562,000 | $845M | $140M | $1.3B |
| Net IncomeAfter-tax profit | -$4M | -$67M | $612M | $57M | $1.9B |
| Free Cash FlowCash after capex | $62M | -$43M | $665M | $206M | $1.9B |
| Gross MarginGross profit ÷ Revenue | +65.7% | +62.2% | +66.4% | +55.1% | +77.0% |
| Operating MarginEBIT ÷ Revenue | +2.6% | -9.6% | +21.9% | +4.7% | +23.1% |
| Net MarginNet income ÷ Revenue | -0.5% | -27.6% | +20.8% | +4.9% | +39.0% |
| FCF MarginFCF ÷ Revenue | +8.6% | -17.4% | +22.6% | +17.6% | +39.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | +5.0% | -19.0% | +9.0% | +9.2% | +5.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +59.6% | +79.4% | +56.5% | +20.0% | +91.4% |
Valuation Metrics
NICE leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 9.9x trailing earnings, NICE trades at a 80% valuation discount to FIVN's 48.3x P/E. Adjusting for growth (PEG ratio), NICE offers better value at 0.37x vs ZM's 0.78x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $372M | $32M | $5.8B | $1.7B | $33.3B |
| Enterprise ValueMkt cap + debt − cash | $694M | $329M | $5.6B | $2.3B | $32.1B |
| Trailing P/EPrice ÷ TTM EPS | -12.71x | -0.22x | 9.89x | 48.26x | 17.53x |
| Forward P/EPrice ÷ next-FY EPS est. | 7.27x | — | 8.74x | 6.96x | 18.44x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 0.37x | — | 0.78x |
| EV / EBITDAEnterprise value multiple | 12.76x | — | 6.59x | 16.84x | 25.52x |
| Price / SalesMarket cap ÷ Revenue | 0.52x | 0.13x | 1.96x | 1.48x | 6.84x |
| Price / BookPrice ÷ Book value/share | 2.84x | — | 1.56x | 2.46x | 3.40x |
| Price / FCFMarket cap ÷ FCF | 7.43x | — | 8.22x | 8.45x | 17.31x |
Profitability & Efficiency
ZM leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
ZM delivers a 19.4% return on equity — every $100 of shareholder capital generates $19 in annual profit, vs $-3 for EGHT. ZM carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to EGHT's 3.36x. On the Piotroski fundamental quality scale (0–9), FIVN scores 8/9 vs LPSN's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -2.7% | — | +16.4% | +7.4% | +19.4% |
| ROA (TTM)Return on assets | -0.6% | -12.4% | +11.8% | +3.2% | +15.9% |
| ROICReturn on invested capital | +2.5% | -6.6% | +13.2% | +1.7% | +10.4% |
| ROCEReturn on capital employed | +2.8% | -5.8% | +16.1% | +2.2% | +11.8% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 5 | 7 | 8 | 7 |
| Debt / EquityFinancial leverage | 3.36x | — | 0.04x | 1.08x | 0.00x |
| Net DebtTotal debt minus cash | $322M | $297M | -$216M | $615M | -$1.2B |
| Cash & Equiv.Liquid assets | $88M | $95M | $379M | $232M | $1.3B |
| Total DebtShort + long-term debt | $410M | $392M | $164M | $847M | $31M |
| Interest CoverageEBIT ÷ Interest expense | 0.69x | 0.20x | — | 7.94x | — |
Total Returns (Dividends Reinvested)
Evenly matched — EGHT and ZM each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in NICE five years ago would be worth $4,090 today (with dividends reinvested), compared to $35 for LPSN. Over the past 12 months, EGHT leads with a +51.7% total return vs LPSN's -77.1%. The 3-year compound annual growth rate (CAGR) favors ZM at 19.9% vs LPSN's -65.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +41.3% | -31.1% | -14.6% | +18.0% | +30.1% |
| 1-Year ReturnPast 12 months | +51.7% | -77.1% | -40.4% | -11.9% | +37.8% |
| 3-Year ReturnCumulative with dividends | -8.2% | -95.8% | -49.3% | -61.4% | +72.2% |
| 5-Year ReturnCumulative with dividends | -90.8% | -99.7% | -59.1% | -87.0% | -63.3% |
| 10-Year ReturnCumulative with dividends | -77.0% | -97.0% | +50.7% | +125.4% | +74.8% |
| CAGR (3Y)Annualised 3-year return | -2.8% | -65.4% | -20.2% | -27.2% | +19.9% |
Risk & Volatility
Evenly matched — NICE and ZM each lead in 1 of 2 comparable metrics.
Risk & Volatility
NICE is the less volatile stock with a 0.72 beta — it tends to amplify market swings less than LPSN's 2.05 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ZM currently trades 99.0% from its 52-week high vs LPSN's 12.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.49x | 2.05x | 0.72x | 1.79x | 0.95x |
| 52-Week HighHighest price in past year | $2.88 | $21.60 | $180.61 | $30.38 | $109.50 |
| 52-Week LowLowest price in past year | $1.56 | $2.37 | $94.89 | $13.29 | $69.15 |
| % of 52W HighCurrent price vs 52-week peak | +92.7% | +12.4% | +53.0% | +73.1% | +99.0% |
| RSI (14)Momentum oscillator 0–100 | 61.1 | 40.3 | 40.9 | 68.1 | 71.2 |
| Avg Volume (50D)Average daily shares traded | 1.2M | 148K | 631K | 2.8M | 4.4M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: EGHT as "Hold", NICE as "Buy", FIVN as "Buy", ZM as "Hold". Consensus price targets imply 640.4% upside for EGHT (target: $20) vs -7.2% for ZM (target: $101).
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | — | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $19.77 | — | $150.88 | $28.40 | $100.56 |
| # AnalystsCovering analysts | 28 | — | 23 | 41 | 48 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | — |
| Dividend StreakConsecutive years of raises | — | — | 0 | — | — |
| Dividend / ShareAnnual DPS | — | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +8.5% | +2.9% | +4.9% |
ZM leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). NICE leads in 1 (Valuation Metrics). 2 tied.
EGHT vs LPSN vs NICE vs FIVN vs ZM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is EGHT or LPSN or NICE or FIVN or ZM a better buy right now?
For growth investors, Five9, Inc.
(FIVN) is the stronger pick with 10. 3% revenue growth year-over-year, versus -22. 0% for LivePerson, Inc. (LPSN). NICE Ltd. (NICE) offers the better valuation at 9. 9x trailing P/E (8. 7x forward), making it the more compelling value choice. Analysts rate NICE Ltd. (NICE) a "Buy" — based on 23 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — EGHT or LPSN or NICE or FIVN or ZM?
On trailing P/E, NICE Ltd.
(NICE) is the cheapest at 9. 9x versus Five9, Inc. at 48. 3x. On forward P/E, Five9, Inc. is actually cheaper at 7. 0x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: NICE Ltd. wins at 0. 33x versus Zoom Communications, Inc. 's 0. 82x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — EGHT or LPSN or NICE or FIVN or ZM?
Over the past 5 years, NICE Ltd.
(NICE) delivered a total return of -59. 1%, compared to -99. 7% for LivePerson, Inc. (LPSN). Over 10 years, the gap is even starker: FIVN returned +125. 4% versus LPSN's -97. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — EGHT or LPSN or NICE or FIVN or ZM?
By beta (market sensitivity over 5 years), NICE Ltd.
(NICE) is the lower-risk stock at 0. 72β versus LivePerson, Inc. 's 2. 05β — meaning LPSN is approximately 183% more volatile than NICE relative to the S&P 500. On balance sheet safety, Zoom Communications, Inc. (ZM) carries a lower debt/equity ratio of 0% versus 3% for 8x8, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — EGHT or LPSN or NICE or FIVN or ZM?
By revenue growth (latest reported year), Five9, Inc.
(FIVN) is pulling ahead at 10. 3% versus -22. 0% for LivePerson, Inc. (LPSN). On earnings-per-share growth, the picture is similar: Five9, Inc. grew EPS 370. 6% year-over-year, compared to 43. 0% for NICE Ltd.. Over a 3-year CAGR, FIVN leads at 13. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — EGHT or LPSN or NICE or FIVN or ZM?
Zoom Communications, Inc.
(ZM) is the more profitable company, earning 39. 0% net margin versus -27. 6% for LivePerson, Inc. — meaning it keeps 39. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ZM leads at 23. 1% versus -9. 6% for LPSN. At the gross margin level — before operating expenses — ZM leads at 77. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is EGHT or LPSN or NICE or FIVN or ZM more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, NICE Ltd. (NICE) is the more undervalued stock at a PEG of 0. 33x versus Zoom Communications, Inc. 's 0. 82x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Five9, Inc. (FIVN) trades at 7. 0x forward P/E versus 18. 4x for Zoom Communications, Inc. — 11. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for EGHT: 640. 4% to $19. 77.
08Which pays a better dividend — EGHT or LPSN or NICE or FIVN or ZM?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is EGHT or LPSN or NICE or FIVN or ZM better for a retirement portfolio?
For long-horizon retirement investors, NICE Ltd.
(NICE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 72)). LivePerson, Inc. (LPSN) carries a higher beta of 2. 05 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (NICE: +50. 7%, LPSN: -97. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between EGHT and LPSN and NICE and FIVN and ZM?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: EGHT is a small-cap quality compounder stock; LPSN is a small-cap quality compounder stock; NICE is a small-cap deep-value stock; FIVN is a small-cap quality compounder stock; ZM is a mid-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.